Outpatient Infusion


RECLAST (also known as Zoledronic Acid)


Reclast, a potent medication in the bisphosphonate class, reduces bone resorption and turnover and results in a net gain in bone mass.


  • Treatment & prevention of postmenopausal osteoporosis
  • Treatment to increase bone mass in men with osteoporosis
  • Treatment and prevention of glucocorticoid-induced osteoporosis
  • Treatment of Paget’s disease of bone in men and women.


Patients with hypocalcemia and renal impairment should consult with their physicians prior to starting Reclast.


Reclast is typically administered as infusion over 15 minutes every 1-2 years for osteoporosis.

Copyright by Thrivewell 2017. All rights reserved.